Michelle A. Lawson

2.9k total citations
67 papers, 1.9k citations indexed

About

Michelle A. Lawson is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Michelle A. Lawson has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 16 papers in Molecular Biology and 16 papers in Hematology. Recurrent topics in Michelle A. Lawson's work include Bone health and treatments (23 papers), Multiple Myeloma Research and Treatments (16 papers) and Virus-based gene therapy research (9 papers). Michelle A. Lawson is often cited by papers focused on Bone health and treatments (23 papers), Multiple Myeloma Research and Treatments (16 papers) and Virus-based gene therapy research (9 papers). Michelle A. Lawson collaborates with scholars based in United Kingdom, United States and Australia. Michelle A. Lawson's co-authors include James T. Triffitt, Richard M. Shelton, L. Wang, Jake E. Barralet, Paul R. Cooper, Andrew Chantry, Jane Christopher‐Hennings, Eric Nelson, Peter I. Croucher and Pete Kaiser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Michelle A. Lawson

65 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle A. Lawson United Kingdom 23 406 387 384 364 316 67 1.9k
Camilla Recordati Italy 23 195 0.5× 224 0.6× 323 0.8× 86 0.2× 76 0.2× 82 1.8k
Norihiko Ito Japan 28 114 0.3× 258 0.7× 488 1.3× 45 0.1× 194 0.6× 133 2.4k
Fan Lee Taiwan 23 112 0.3× 560 1.4× 487 1.3× 78 0.2× 226 0.7× 83 2.3k
Jianfeng Han China 33 836 2.1× 385 1.0× 1.1k 2.7× 89 0.2× 554 1.8× 102 3.3k
Akira Takeda Japan 23 149 0.4× 147 0.4× 678 1.8× 43 0.1× 185 0.6× 146 2.5k
Xing Zhao China 26 221 0.5× 192 0.5× 392 1.0× 75 0.2× 116 0.4× 79 1.7k
Yuanyuan Xu United States 24 91 0.2× 630 1.6× 319 0.8× 70 0.2× 189 0.6× 44 2.2k
M.A. Lizarbe Spain 28 388 1.0× 201 0.5× 1.6k 4.2× 392 1.1× 36 0.1× 76 3.1k
Javier Turnay Spain 28 406 1.0× 236 0.6× 1.6k 4.1× 436 1.2× 39 0.1× 68 3.2k

Countries citing papers authored by Michelle A. Lawson

Since Specialization
Citations

This map shows the geographic impact of Michelle A. Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Lawson more than expected).

Fields of papers citing papers by Michelle A. Lawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Lawson. The network helps show where Michelle A. Lawson may publish in the future.

Co-authorship network of co-authors of Michelle A. Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Lawson. A scholar is included among the top collaborators of Michelle A. Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Lawson. Michelle A. Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tazzyman, Simon, Yidan Sun, Darren Lath, et al.. (2025). An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy. Leukemia. 39(6). 1449–1463.
2.
Blount, Daniel G., Naeem Khan, Laura Moyce, et al.. (2024). Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 24(1). 93–104. 2 indexed citations
3.
Evans, Holly, Goran Lovrić, Andrew Chantry, et al.. (2024). Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease. JBMR Plus. 8(9). ziae093–ziae093. 2 indexed citations
4.
Tazzyman, Simon, Darren Lath, Joe Conner, et al.. (2023). HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models. Viruses. 15(3). 603–603. 4 indexed citations
5.
Latif, Norain Ab., et al.. (2022). The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. Oncogene. 42(4). 259–277. 16 indexed citations
6.
Chantry, Andrew, et al.. (2021). The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma. Cancers. 13(22). 5687–5687. 6 indexed citations
7.
Migneco, G, Gina B. Scott, Jenny Down, et al.. (2021). Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer. 9(3). e001803–e001803. 14 indexed citations
8.
Brown, Janet E., et al.. (2021). Myeloma Bone Disease: The Osteoblast in the Spotlight. Journal of Clinical Medicine. 10(17). 3973–3973. 8 indexed citations
9.
Diaz‐delCastillo, Marta, et al.. (2019). Differential Pain‐Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma. JBMR Plus. 4(2). e10252–e10252. 5 indexed citations
10.
Green, Alanna C., Darren Lath, Brant Walkley, et al.. (2019). TGFβ Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance in a Murine Myeloma Model. Journal of Bone and Mineral Research. 34(12). 2311–2326. 17 indexed citations
11.
Paton‐Hough, Julia, Andrew Chantry, & Michelle A. Lawson. (2015). A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease. Bone. 77. 57–68. 31 indexed citations
12.
Bassett, J. H. Duncan, A. Boyde, Peter Howell, et al.. (2010). Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proceedings of the National Academy of Sciences. 107(16). 7604–7609. 104 indexed citations
13.
14.
Xia, Zhidao, James E. Dunford, Michelle A. Lawson, et al.. (2007). Predicting the clinical potencies of bisphosphonates: Divergence of hydroxyapatite and farnesyl diphosphate synthase binding affinities. Calcified Tissue International. 80. 2 indexed citations
15.
Xia, Zhidao, Michelle A. Lawson, James T. Triffitt, et al.. (2006). A novel method to characterize relative mineral binding affinities of bisphosphonates and the structural requirements for binding by using ceramic hydroxyapatite column chromatography.. Journal of Bone and Mineral Research. 21. 1 indexed citations
16.
Lawson, Michelle A., J T Triffitt, Frank H. Ebetino, et al.. (2005). Differences in the potential binding of phosphate containing compounds to bone mineral are revealed by the novel use of hydroxyapatite column chromatography. Journal of Bone and Mineral Research. 20. 1303–1303. 1 indexed citations
17.
Lawson, Michelle A., J T Triffitt, Frank H. Ebetino, et al.. (2005). Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.. Oxford University Research Archive (ORA) (University of Oxford). 5 indexed citations
18.
Lawson, Michelle A., Lisa Rothwell, & Pete Kaiser. (2000). Turkey and Chicken Interleukin-2 Cross-React in In Vitro Proliferation Assays Despite Limited Amino Acid Sequence Identity. Journal of Interferon & Cytokine Research. 20(2). 161–170. 35 indexed citations
19.
Jaffe, Howard, Joseph O’Neill, Paul L. Hallberg, et al.. (1990). Isolation and identification of a peptide from rat brain which inhibits [3H]TCP binding. International Journal of Biochemistry. 22(3). 239–245. 1 indexed citations
20.
Rutledge, L. C., et al.. (1981). Noncorrelation of insecticide and repellent tolerances in representative species and strains of mosquitoes.. Mosquito news. 41(4). 684–688. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camilla Recordati Breakdown of academic impact, for papers by Norihiko Ito Breakdown of academic impact, for papers by Fan Lee Breakdown of academic impact, for papers by Jianfeng Han Breakdown of academic impact, for papers by Akira Takeda Breakdown of academic impact, for papers by Xing Zhao Breakdown of academic impact, for papers by Yuanyuan Xu Breakdown of academic impact, for papers by M.A. Lizarbe Breakdown of academic impact, for papers by Javier Turnay
Rankless by CCL
2026